Pfizer’s Bourla Defends Cancer Drug Pricing
This article was originally published in The Pink Sheet Daily
Executive Summary
“We should not discourage innovation right now,” Pfizer’s Group President of Vaccines, Oncology and Consumer Healthcare Albert Bourla said during a media briefing at the company headquarters.